Literature DB >> 28875851

Urotensin II: Molecular Mechanisms of Biological Activity.

Andrey A Svistunov1, Vadim V Tarasov1, Svetlana A Shakhmardanova1, Susanna S Sologova1, Ekaterina T Bagaturiya1, Vladimir N Chubarev1, Pavel A Galenko-Yaroshevsky2, Marco Fidel Avila-Rodriguez3, George E Barreto4,5, Gjumrakch Aliev6,7,8.   

Abstract

Urotensin II (UT II) is an important factor of cellular homeostasis. This regulatory peptide is involved in the pathophysiology of many disorders. For example, it plays an important role in the pathogenesis of acute and chronic diseases, stressful and adaptive reactions of the body, in the development of cardiovascular pathologies, metabolic syndrome, inflammation, liver cirrhosis, renal failure, diabetic nephropathy, reproductive dysfunction, progression of psychosomatic, psychoendocrinal and psychiatric disorders. In this concern, the involvement of UT II in the pathophysiology of many processes determines the perspectives for the development of blockers of urotensin receptors for the treatment of the aforementioned diseases. It is important that even today this kind of perspective is feasible due to the synthesis of a series of GPR14 blockers. The objective of this review is to discuss current molecular mechanisms of biological activity, regulatory functions of UT II, its role in the pathogenesis of different nosologies, as well as analysis of the possible routes of exposure to GPR14 as potential therapeutic targets. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  G-protein-coupled receptors; drug design; Urotensin II; cancer; hormonal systems; kidney; molecular targets of Urotensin II in cardiovascular; nervous; regulatory peptides; sexual function; stress.

Mesh:

Substances:

Year:  2018        PMID: 28875851     DOI: 10.2174/1389203718666170829162335

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  5 in total

Review 1.  Targeting of G-protein coupled receptors in sepsis.

Authors:  Abdul Rehman; Noor Ul-Ain Baloch; John P Morrow; Pál Pacher; György Haskó
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

2.  Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway.

Authors:  Haipeng Cui; Yingxue Lin; Lide Xie; Juan Zhao
Journal:  Mol Med Rep       Date:  2021-02-19       Impact factor: 2.952

Review 3.  The Effect of Local Renin Angiotensin System in the Common Types of Cancer.

Authors:  Moudhi Almutlaq; Abir Abdullah Alamro; Hassan S Alamri; Amani Ahmed Alghamdi; Tlili Barhoumi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-03       Impact factor: 5.555

4.  Urotensin II level is elevated in inflammatory bowel disease patients.

Authors:  Yan Zhang; Guo-Xun Chen
Journal:  World J Gastroenterol       Date:  2022-09-21       Impact factor: 5.374

Review 5.  Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.

Authors:  Devang M Patel; Madhura Bose; Mark E Cooper
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.